MUM1/IRF4 expression in the circulating compartment of chronic lymphocytic leukemia. (Q53501896)

14 May 2018

title

MUM1/IRF4 expression in the circulating compartment of chronic lymphocytic leukemia. (English)

1 reference

14 May 2018

0 references

1 reference

3

1 reference

14 May 2018

author name string

Fiona Craig

1

1 reference

14 May 2018

Lorinda Soma

2

1 reference

14 May 2018

Jeffrey Kant

4

1 reference

14 May 2018

Steven Swerdlow

5

1 reference

14 May 2018

publication date

1 February 2008

1 reference

14 May 2018

published in

Leukemia & Lymphoma

1 reference

14 May 2018

volume

49

1 reference

14 May 2018

issue

2

1 reference

14 May 2018

page(s)

273-280

1 reference

14 May 2018

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

cites work

1 reference

https://api.crossref.org/works/10.1080/10428190701760037

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190701760037

MUM1/IRF4 expression is an unfavorable prognostic factor in B-cell chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190701760037

The proliferation center microenvironment and prognostic markers in chronic lymphocytic leukemia/small lymphocytic lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190701760037

ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190701760037

ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190701760037

Chronic lymphocytic leukemia: revelations from the B-cell receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190701760037

Recent advances in the molecular biology and immunobiology of chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190701760037

ZAP-70 directly enhances IgM signaling in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190701760037

The role of IRF-4 in B and T cell activation and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190701760037

Lineage-specific modulation of interleukin 4 signaling by interferon regulatory factor 4

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190701760037

B-lymphocyte quiescence, tolerance and activation as viewed by global gene expression profiling on microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190701760037

Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190701760037

Multiple myeloma oncogene 1 (MUM1)/interferon regulatory factor 4 (IRF4) upregulates monokine induced by interferon-gamma (MIG) gene expression in B-cell malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190701760037

The pattern of CD38 expression defines a distinct subset of chronic lymphocytic leukemia (CLL) patients at risk of disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190701760037

Chronic lymphocytic leukaemia: one disease or two?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190701760037

ZAP-70 expression and prognosis in chronic lymphocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190701760037

CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190701760037

Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190701760037

CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190701760037

10.1080/10428190701760037

21 January 2018

Identifiers

DOI

1 reference

14 May 2018

1 reference

14 May 2018